Company Filing History:
Years Active: 2018
Title: Fabian Freiberg: Innovator in Cardiac Treatment
Introduction
Fabian Freiberg is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of heart disease. His innovative approach focuses on the inhibition of the Coxsackievirus-Adenovirus Receptor, which plays a crucial role in cardiac health.
Latest Patents
Fabian Freiberg holds a patent titled "Method for treating heart disease by inhibiting the Coxsackievirus-Adenovirus Receptor." This invention pertains to a means for downregulating or inhibiting or mislocalizing CAR in a cardiac cell. It aims to treat or cure patients who have suffered or are predisposed to suffering a myocardial infarction (MI) or to prevent myocardial infarction and its complications. He has 1 patent to his name.
Career Highlights
Throughout his career, Freiberg has worked with prestigious institutions, including the Max Delbrück Center for Molecular Medicine in Berlin-Buch and the Max Delbrück Center for Molecular Medicine in the Helmholtz Association. His work in these centers has allowed him to advance his research and contribute to significant medical innovations.
Collaborations
Fabian Freiberg has collaborated with various professionals in his field, including his coworker Michael Gotthardt. Their joint efforts have furthered research in cardiac treatments and have the potential to impact patient care positively.
Conclusion
Fabian Freiberg is a pioneering inventor whose work in cardiac treatment showcases the importance of innovation in medicine. His contributions are vital for advancing healthcare solutions for heart disease.